PL2826856T3 - Genetycznie stabilny onkolityczny wirus RNA, sposób jego wytwarzania i zastosowanie - Google Patents

Genetycznie stabilny onkolityczny wirus RNA, sposób jego wytwarzania i zastosowanie

Info

Publication number
PL2826856T3
PL2826856T3 PL13176757T PL13176757T PL2826856T3 PL 2826856 T3 PL2826856 T3 PL 2826856T3 PL 13176757 T PL13176757 T PL 13176757T PL 13176757 T PL13176757 T PL 13176757T PL 2826856 T3 PL2826856 T3 PL 2826856T3
Authority
PL
Poland
Prior art keywords
manufacturing
rna virus
genetically stable
oncolytic rna
stable oncolytic
Prior art date
Application number
PL13176757T
Other languages
English (en)
Inventor
Dite Venskus
Ivars Kalvins
Dace Pjanova
Ramona PETROVSKA
Jurgis Auzins
Original Assignee
Sia Latima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sia Latima filed Critical Sia Latima
Publication of PL2826856T3 publication Critical patent/PL2826856T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL13176757T 2013-07-16 2013-07-16 Genetycznie stabilny onkolityczny wirus RNA, sposób jego wytwarzania i zastosowanie PL2826856T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13176757.6A EP2826856B9 (en) 2013-07-16 2013-07-16 Genetically stable oncolytic RNA virus, method of manufacturing and use thereof

Publications (1)

Publication Number Publication Date
PL2826856T3 true PL2826856T3 (pl) 2016-06-30

Family

ID=48790285

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13176757T PL2826856T3 (pl) 2013-07-16 2013-07-16 Genetycznie stabilny onkolityczny wirus RNA, sposób jego wytwarzania i zastosowanie
PL14747317.7T PL3022297T3 (pl) 2013-07-16 2014-07-16 Stabilny genetycznie onkolityczny wirus rna, sposób jego wytwarzania i zastosowanie

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL14747317.7T PL3022297T3 (pl) 2013-07-16 2014-07-16 Stabilny genetycznie onkolityczny wirus rna, sposób jego wytwarzania i zastosowanie

Country Status (16)

Country Link
US (2) US10174291B2 (pl)
EP (2) EP2826856B9 (pl)
JP (1) JP6293882B2 (pl)
CN (2) CN105518128B (pl)
AU (1) AU2014292114B2 (pl)
BR (1) BR112016000874B1 (pl)
CA (1) CA2917584C (pl)
EA (1) EA032977B1 (pl)
ES (1) ES2566146T3 (pl)
GE (1) GEP201706763B (pl)
HK (1) HK1219500A1 (pl)
MD (1) MD4480C1 (pl)
MX (1) MX365075B (pl)
PL (2) PL2826856T3 (pl)
UA (1) UA116387C2 (pl)
WO (1) WO2015007788A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109276580B (zh) * 2017-07-21 2021-08-24 厦门大学 一种用于治疗肿瘤的病毒
CN109419818B (zh) * 2017-08-24 2021-08-10 厦门大学 一种用于治疗肿瘤的埃可病毒
CN107669707A (zh) * 2017-11-16 2018-02-09 邹罡 埃可病毒作为溶瘤病毒在抗肿瘤中的应用
CN110064044B (zh) * 2018-01-20 2022-09-09 中国科学院武汉病毒研究所 一种肠道病毒71型的抑制剂及应用
GB201808500D0 (en) 2018-05-23 2018-07-11 Ditesan Ltd Virus and virus use
WO2020035423A1 (en) 2018-08-13 2020-02-20 Ditesan Ltd. Combination therapy of cancer by administrating echo-7 virus and a pharmaceutically effective anti-cancer drug

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987101A (en) 1988-12-16 1991-01-22 International Business Machines Corporation Method for providing improved insulation in VLSI and ULSI circuits
CN1244583A (zh) * 1998-08-12 2000-02-16 财团法人生物技术开发中心 本土性猪水泡病病毒与其变异株的制备方法及用途
CA2386920C (en) * 1999-09-17 2012-01-24 Pro-Virus, Inc. Oncolytic virus
AUPQ425699A0 (en) * 1999-11-25 1999-12-23 University Of Newcastle Research Associates Limited, The A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
US6602862B1 (en) * 2000-09-19 2003-08-05 Merz Pharma Gmbh & Co., Kgaa 1-Amino-alkylcyclohexanes as trypanocidal agents
WO2002072027A2 (en) * 2001-03-14 2002-09-19 University Of Alabama Research Foundation Oncolytic rna replicons
LV12861B (lv) 2002-06-14 2002-10-20 Aina Muceniece Imūnstimulators ar pretaudzēja aktivitāti un tā iegūšanas paņēmiens
AU2002953436A0 (en) * 2002-12-18 2003-01-09 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
WO2004094454A2 (en) * 2003-04-18 2004-11-04 Idm Pharma, Inc. Hla-a2 tumor associated antigen peptides and compositions
WO2006074526A1 (en) * 2005-01-17 2006-07-20 Viralytics Limited Method and composition for treatment of neoplasms
CA2673520A1 (en) * 2006-12-22 2008-07-03 Bayer Schering Pharma Aktiengesellschaft Generation of oncolytic adenoviruses and uses thereof
US10722562B2 (en) * 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
CA2689707A1 (en) * 2009-11-16 2011-05-16 Jean-Simon Diallo Identification of the novel small molecule viral sensitizer vse1 using high-throughput screening

Also Published As

Publication number Publication date
UA116387C2 (uk) 2018-03-12
US10174291B2 (en) 2019-01-08
EP2826856B9 (en) 2016-05-04
HK1219500A1 (zh) 2017-04-07
EA201690232A1 (ru) 2016-05-31
US20190144833A1 (en) 2019-05-16
EP3022297A1 (en) 2016-05-25
MX2016000462A (es) 2016-07-26
JP2016529886A (ja) 2016-09-29
US20160376562A1 (en) 2016-12-29
EA032977B1 (ru) 2019-08-30
CA2917584A1 (en) 2015-01-22
ES2566146T3 (es) 2016-04-11
GEP201706763B (en) 2017-10-25
CN105518128A (zh) 2016-04-20
CN105518128B (zh) 2019-07-09
AU2014292114B2 (en) 2018-12-20
CN110129284A (zh) 2019-08-16
PL3022297T3 (pl) 2023-12-18
BR112016000874B1 (pt) 2019-07-16
MX365075B (es) 2019-05-22
JP6293882B2 (ja) 2018-03-14
WO2015007788A1 (en) 2015-01-22
CA2917584C (en) 2018-02-27
EP3022297B1 (en) 2023-07-05
EP2826856B1 (en) 2015-12-23
EP3022297C0 (en) 2023-07-05
BR112016000874A2 (pt) 2017-03-21
AU2014292114A1 (en) 2016-02-18
MD4480C1 (ro) 2017-12-31
MD20160014A2 (ro) 2016-07-31
EP2826856A1 (en) 2015-01-21
US10435672B2 (en) 2019-10-08
MD4480B1 (ro) 2017-05-31

Similar Documents

Publication Publication Date Title
IL264385B (en) Newcastle disease viruses and their use
HK1255037A1 (zh) 製備烟酰胺核苷和其衍生物的方法
HK1219975A1 (zh) 用於病毒生產的細胞系和使用方法
IL240881A0 (en) Expression of the t cell balance gene, preparations, materials and methods for its use
IL243672B (en) Circulation and amplification of ligase-assisted nucleic acids
LT3459965T (lt) Viruso prototipo sekų ir jų panaudojimo prognozavimo metodai
EP2971116A4 (en) EXPRESSION OF DENDRITIC CELL RESPONSE GENE, COMPOSITIONS OF MATERIALS AND METHODS OF USE THEREOF
HK1219500A1 (zh) 遺傳穩定的溶瘤性 病毒、其製備方法及用途
HK1223110A1 (zh) 流行性感冒病毒疫苗及其用途
HK1209324A1 (en) Nanozymes, methods of making nanozymes, and methods of using nanozymes
EP3085784A4 (en) Nucleic acid inducing rna interference modified for preventing off-target, and use thereof
IL240936B (en) Reassortment of influenza virus and methods for their preparation
GB201319878D0 (en) Method, Array and use thereof
IL243030B (en) Cell populations, methods to go through the process of "change of purpose", and methods of using them
PL2988764T3 (pl) Kompozycje przeciwłupieżowe i sposoby ich zastosowania
HK1198836A1 (en) Whole genome amplification method and application thereof
EP3085454C0 (en) REVERSE FLOW TYPE AGGLOMERATOR COLLECTOR CYCLONE, DUST COLLECTION METHOD AND THEIR USE
DK2805954T3 (da) 7-substitueret hanfangichin b-derivat, og fremstillingsfremgangsmåde og anvendelse deraf
EP2952519A4 (en) PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
HK1246824A1 (zh) 應用人脂肪衍生的幹細胞增殖血清來源的丙肝病毒及其用途
EP2975119A4 (en) CELL STRAIN HAVING INCREASED VIRUS PRODUCTION CAPACITY AND METHOD FOR PRODUCING THE SAME
HK1217670A1 (zh) 調配物、其製造方法和用途
HK1244814A1 (zh) 一種薯蕷皂苷元-3-位衍生物及其製備方法和用途
GB201405961D0 (en) Single use baby chnaging pack, method of assembly thereof and method of use thereof
SG11201507455WA (en) Hepatitis b virus vaccines